Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Giorgi C, Marchi S, Simoes ICM, Ren Z, Morciano G, Perrone M, et al
The peptide's development focused on enhancing hydrophobicity, decreasing hydrogen bonding potential, and increasing metabolic stability, resulting in a compound with an exceptionally long plasma half-life of approximately 335 minutes
Subcutaneous injection delivers the peptide directly into the bloodstream, bypassing digestive degradation making it the preferred route for musculoskeletal or systemic applications
Primary antibodies were then added and incubated overnight at 4 C, followed by incubation with secondary antibodies
10.1016/j.stem.2023.08.001 143 WildS
US$ 25.58
US$ 21.96
US$ 27.08
US$ 24.48
US$ 27.74
US$ 26.69
